Viveve Medical Inc (VIVE)
0.0002
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
Viveve Medical Cash from Operations (TTM): -16.23M for Sept. 30, 2022
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2022 | -16.23M |
June 30, 2022 | -15.54M |
March 31, 2022 | -14.71M |
December 31, 2021 | -12.88M |
September 30, 2021 | -11.95M |
June 30, 2021 | -12.03M |
March 31, 2021 | -12.75M |
December 31, 2020 | -15.23M |
September 30, 2020 | -18.31M |
June 30, 2020 | -22.17M |
March 31, 2020 | -25.41M |
December 31, 2019 | -31.24M |
September 30, 2019 | -35.71M |
June 30, 2019 | -39.11M |
March 31, 2019 | -39.46M |
December 31, 2018 | -43.09M |
September 30, 2018 | -41.82M |
June 30, 2018 | -40.76M |
March 31, 2018 | -42.00M |
December 31, 2017 | -34.85M |
September 30, 2017 | -32.17M |
June 30, 2017 | -29.12M |
March 31, 2017 | -24.09M |
December 31, 2016 | -18.09M |
September 30, 2016 | -16.06M |
Date | Value |
---|---|
June 30, 2016 | -13.42M |
March 31, 2016 | -12.57M |
December 31, 2015 | -12.20M |
September 30, 2015 | -10.27M |
June 30, 2015 | -9.888M |
March 31, 2015 | -7.034M |
December 31, 2014 | -5.991M |
September 30, 2014 | -4.666M |
June 30, 2014 | -3.109M |
March 31, 2014 | -3.277M |
December 31, 2013 | -4.804M |
September 30, 2013 | -4.791M |
June 30, 2013 | -4.571M |
March 31, 2013 | -4.374M |
December 31, 2012 | -3.165M |
September 30, 2012 | -3.195M |
June 30, 2012 | -2.945M |
March 31, 2012 | -3.655M |
December 31, 2011 | -3.393M |
September 30, 2011 | -2.761M |
June 30, 2011 | -2.126M |
March 31, 2011 | -1.22M |
December 31, 2010 | -1.348M |
September 30, 2010 | -1.905M |
June 30, 2010 | -2.013M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-39.11M
Minimum
Jun 2019
-11.95M
Maximum
Sep 2021
-20.23M
Average
-15.89M
Median
Cash from Operations (TTM) Benchmarks
HTG Molecular Diagnostics Inc | -16.83M |
Minerva Surgical Inc | -38.73M |
Stereotaxis Inc | -9.139M |
Electromed Inc | 4.872M |
Myomo Inc | -6.173M |